Login to Your Account



Astrazeneca, S. Korean government ink translational R&D deal

By Cornelia Zou
Staff Writer

Wednesday, March 12, 2014

HONG KONG – South Korea has a serious cancer problem. Between 2001 and 2011, the number of cancer patients doubled to more than 218,000.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription